Wed 25 Nov 2009 | 13:04 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Sciclone Pharmaceuticals Inc

Sciclone Pharmaceuticals Inc (SCLN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View SCLN on other exchanges
As of  12:42pm EST
2.52USD
Price Change
+0.03
Percent Change
+1.20%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Rios, Israel 62 -- Senior Vice President - Medical Affairs, Chief Medical Officer
Schmid, Hans 57 2007 President, Managing Director of SciClone Pharmaceuticals International Ltd.
Blobel, Friedhelm 60 2008 President, Chief Executive Officer, Director
Woodman, Dean 80 2009 Director
Hawkins, Richard 60 2004 Director
Lawrence, Ira 55 2006 Director
Camerini, Roberto 45 2009 Director
Jones, Trevor 66 2009 Director
Lapointe, Gregg 50 2009 Director
Titus, Gary 49 2008 Chief Financial Officer, Senior Vice President - Finance
Saxe, Jon 72 2009 Chairman of the Board